← All stocks

RenovoRx, Inc.

RNXT Net buying

CIK 0001574094 #4619 in the set updated 20 Sep 2026

Bought (12 mo)

$84.43K

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$0.00

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$0.00

0 of 0 sales

Net

+$84.43K

+$84.43K against sales at will

By person

5 insiders · 13 transactions

0.8×

Shaun R. Bagai holds only 0.8 times base salary in stock. $514.62K of shares against $583.44K in salary for 2025.

Salary from the company's own proxy. The shares are what Shaun R. Bagai last reported holding, valued at $0.79, the price Common Stock was last bought or sold at on the open market here, on 19 May 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Agah Ramtin

Chief Medical Officer

$55.97K (7)

—

+$55.97K

798,460

1.77%

$628.87K

−21.9%

VOLL MARK

Chief Financial Officer

$19.69K (2)

—

+$19.69K

416,780

0.9235%

$328.26K

+241.1%

Bagai Shaun

Chief Executive Officer

$8.77K (3)

—

+$8.77K

653,397

1.45%

$514.62K

+12.3%

Marton Laurence

Director

— (1)

—

$0.00

75,884

0.1681%

$59.77K

+125.6%

Kocak Ron

VP, Controller and PAO

—

12,595

0.0279%

$9.92K

—

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 23

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 0

Sales at will 0

Transactions with no price 3

Shares from compensation/vesting 172,380

History held since 4 Oct 2021